|

In-situ vs Ex-situ Liver Preservation

RECRUITINGN/ASponsored by Leiden University Medical Center
Actively Recruiting
PhaseN/A
SponsorLeiden University Medical Center
Started2026-10-01
Est. completion2031-10-01
Eligibility
Age16 Years+
Healthy vol.Accepted

Summary

The goal of this Randomized Controlled Trial is to learn what machine preservation method is most clinically effective for liver transplantation (LTx) after donation after circulatory death (DCD). The main questions it aims to answer are: * What perfusion method has the lowest death censored biliary complication rate at 1-year post LT? * Are there differences in the Core Outcome Set of liver transplantation outcomes? * Are there any differences in utilization outcomes? * Are there any differences in cost effectiveness? * Are there any differences in patient quality of life? * Are there any differences in resource utilization? Researchers will compare preservation using in-situ abdominal normothermic regional perfusion (aNRP) to (dual) hypothermic oxygenated perfusion (DHOPE) or DHOPE followed by controlled oxygenated rewarming and normothermic machine perfusion (DHOPE-COR-NMP). Nothing will change from clinical practice for the liver recipients.

Eligibility

Age: 16 Years+Healthy volunteers accepted
Inclusion Criteria:

* All DCD donor livers (donor=\>16 years) accepted for transplantation in the Netherlands

Exclusion Criteria:

* HU recipients
* Logistical or technical constraints for machine perfusion

Conditions3

Liver DiseaseLiver Disease (Alcoholic or Not)Transplantation

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.